We have the ability to regenerate our bones after minor fractures throughout most of our adult life. But our bones are unable to effectively and efficiently recover from larger defects such as osteoporosis.

Connecting Australian scientific talent and infrastructure to the world, and promoting the remarkable opportunities in Australia is a particular passion of Andrew Lonie’s.

A/Professor Max Cryle, Senior Research Fellow and EMBL Group Leader at Monash University has been instrumental in helping his final year PhD student (based in Copenhagen) access crystallisation facilities at EMBL- Hamburg.

As EMBL Director, Professor Matthias Hentze advises and works closely with EMBL’s Director General. Matthias oversees the areas of Resource Development and Alumni Relations, and is supported by the Director's Office.

The past year has seen EMBL Australia expand considerably, with our node at the South Australian Health and Medical Research Institute becoming firmly established and a new node created at the University of New South Wales. Both these nodes are recruiting group leaders for further expansion, as are the Victorian node at the Australian Regenerative Medicine Institute at Monash University and a new node at the Centre of Excellence in Advanced Molecular Imaging, also based at Monash University.

• ACABS conference October 2015 - brief overview
• Profile - A/Professor James Bourne, EMBL-Australia Collaborating Group Leader, Monash University
• Successful candidates of the joint EMBL Australia and UNSW postgraduate scholarships pilot programme announced
• EMBL Australia Postgraduate Symposium 2015 – Recap and Reflection
• EMBL Australia Bioinformatics Resource holds Intensive training in Cancer Genomics and the Genome Analysis Tool Kit in Melbourne and Sydney in February
• Post-doctoral Fellowship opportunities at EMBL Australia and Post-graduate opportunities at EMBL 
• EMBL Showcase planned for July 2016, ANU Canberra
• Change of date for 2016 EMBL Australia, Student PhD symposium, 16-18 November, SAHRMI, Adelaide 
• Internships still available for MSc or PhD students at Merrimack Pharmaceuticals

• Dr Pirjo Apaja appointed as EMBL Australia Group Leader, SAHMRI
• Internships still available for MSc or PhD students at Merrimack Pharmaceuticals

• Thanks to support from the EMBL Australia Bioinformatics Resource, CSIRO’s Annette McGrath attends GOBLET and secures 2016 GOBLET AGM
• Dr Vicky Schneider announced as Deputy Director, EMBL Australia Bioinformatics Resource
• EMBL Showcase planned for early July 2016
• Announcement of the EMBL Australia, 2016 PhD symposium followed by the success of 2015 Australian PhD symposium, Melbourne
• EMBL Heidelberg - seeking highly motivated student to join the Protein Expression and Purification Core Facility
• Internships still available for MSc or PhD students at Merrimack Pharmaceuticals

• Remarkable research infrastructure that can be accessed at EMBL Australia - BRAEMBL
• Dr Niklas Blomberg, Director, ELIXIR, EMBL (UK), visiting in early December 
• Dr Max Cryle appointed as EMBL Australia, Group Leader, Monash University 
• Profile - Prof Thomas Preiss, EMBL-Australia, Collaborating Group Leader, ANU
• Feedback from Student PhD Symposium and EMBL Noncoding Genome Conference, EMBL Heidelberg 
• EMBL Heidelberg - seeking highly motivated student to join the Protein Expression and Purification Core Facility 
• BioInfoSummer, 7-10 December, 2015 Registration still open 
• Internships still available for MSc or PhD students at Merrimack Pharmaceuticals

• New members of EMBL Australia announced
• A/Professor Andrew Lonie appointed Director, Victorian Life Sciences Computation Initiative (VLSCI)
• Dr Mikaël Martino appointed as EMBL Australia Group Leader at the Australian Regenerative Medicine Institute in the Victorian node
• Professor Kat Gaus, Node Head, EMBL Australia in Single Molecule Science, New South Wales - Profile
• Professor Steve Wesselingh, Node Head, South Australia- Profile
• Reminder, BioInfoSummer – 2015, University of Sydney
• Internships still available for MSc or PhD students at Merrimack Pharmaceuticals
• About EMBL Australia